Abstract
Euglycaemic diabetic ketoacidosis (eu-DKA) is a rare but serious complication of sodium-glucose co-transporter 2 (SGLT2) inhibitors, characterized by metabolic acidosis, elevated ketones and may be overlooked because of the absence of marked hyperglycaemia. We present the case of a 57-year-old male with well-controlled type 2 diabetes (HbA1c 6.5%), hypertension and squamous cell carcinoma of the tongue, admitted to Aga Khan University Hospital, Karachi, Pakistan for elective surgery. The diagnosis of euglycaemic DKA was incidental as the patient was asymptomatic and metabolic abnormalities were detected during preoperative laboratory evaluation. Investigations revealed high anion gap metabolic acidosis with ketonuria and a normal blood glucose level (73 mg/dL). He had been on SGLT2 inhibitors and had abstained from solid food intake for two weeks due to his cancer diagnosis. Management included intravenous fluids, insulin infusion and electrolyte monitoring. His metabolic parameters normalized within 8 hours and he was placed on an adjusted basal-bolus insulin regimen.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1354-1356 |
| Number of pages | 3 |
| Journal | Journal of the Pakistan Medical Association |
| Volume | 76 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 14 Jul 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- DKA
- Diabetes Mellitus
- Diabetic Ketoacidosis
- SGLT-2 Inhibitors
- Sodium Glucose Transporter 2 Inhibitors
- Type II
Fingerprint
Dive into the research topics of 'Incidental diagnosis of euglycaemic diabetic ketoacidosis: A case report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver